Redefining ventilator-associated pneumonia treatment: a novel economic analysis of tobramycin and colistin's cost-effectiveness.

Buendía JA, Buendia Sánchez JA, Guerrero Patino D

Open source

DOI
10.1186/s12890-025-03797-5
Published
2025 Jul 22
Container
BMC pulmonary medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12890-025-03797-5,
  title = {Redefining ventilator-associated pneumonia treatment: a novel economic analysis of tobramycin and colistin's cost-effectiveness.},
  author = {Buendía JA and Buendia Sánchez JA and Guerrero Patino D},
  year = {2025},
  journal = {BMC pulmonary medicine},
  doi = {10.1186/s12890-025-03797-5},
  url = {https://doi.org/10.1186/s12890-025-03797-5}
}

RIS

TY  - JOUR
TI  - Redefining ventilator-associated pneumonia treatment: a novel economic analysis of tobramycin and colistin's cost-effectiveness.
AU  - Buendía JA
AU  - Buendia Sánchez JA
AU  - Guerrero Patino D
PY  - 2025
JO  - BMC pulmonary medicine
DO  - 10.1186/s12890-025-03797-5
UR  - https://doi.org/10.1186/s12890-025-03797-5
ER  - 

APA

JA, B., JA, B. S., & D, G. P. (2025). Redefining ventilator-associated pneumonia treatment: a novel economic analysis of tobramycin and colistin's cost-effectiveness.. BMC pulmonary medicine. https://doi.org/10.1186/s12890-025-03797-5

Source records